Veru Inc.
- VERU
- NASDAQ
- Biotechnology
- Cancer Therapeutics
- Contraceptives (FC2)
$2.30
Today −5.74%Quote Oct 16, 2026, 08:00 PM UTC
−3.77%over the last month
Max drawdown −19.9%From 1-month high −13.5%3 months 0.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$39.2M
Quote Oct 16
Next earnings
Nov 26
Expected, not confirmed
Analyst target
$4.00
+73.9% from here
Floor
$2.29
0.5% below price
Where the price sits
7 analysts
Analyst range, low to high
$3.00$5.00
- Price $2.30
- Resistance $2.32
- Consensus $4.00
The price is just above its floor and right under resistance. Analysts' average target sits about 74% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VERUPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
20